Gastroenterology
Volume 129, Issue 3 , Pages 786-796, September 2005

Limited Efficiency of Prolyl-Endopeptidase in the Detoxification of Gliadin Peptides in Celiac Disease

  • Tamara Matysiak–Budnik

      Affiliations

    • INSERM EMI-0212, Faculté Necker-Enfants Malades, Paris, France
    • Corresponding Author InformationAddress requests for reprints to: Tamara Matysiak–Budnik, MD, PhD, INSERM EMI-0212, Faculté Necker-Enfants Malades, 156 rue de Vaugirard, 75730 Paris, France.fax: (33) 0-1-40-61-56-38
  • ,
  • Celine Candalh

      Affiliations

    • INSERM EMI-0212, Faculté Necker-Enfants Malades, Paris, France
  • ,
  • Christophe Cellier

      Affiliations

    • Hôpital Européen Georges Pompidou, Paris, France
  • ,
  • Christophe Dugave

      Affiliations

    • Laboratoire DIEP, CEA/Saclay, Gif sur Yvette, France
  • ,
  • Abdelkader Namane

      Affiliations

    • Institut Pasteur, Paris, France
  • ,
  • Teresita Vidal–Martinez

      Affiliations

    • INSERM EMI-0212, Faculté Necker-Enfants Malades, Paris, France
  • ,
  • Nadine Cerf–Bensussan

      Affiliations

    • INSERM EMI-0212, Faculté Necker-Enfants Malades, Paris, France
  • ,
  • Martine Heyman

      Affiliations

    • INSERM EMI-0212, Faculté Necker-Enfants Malades, Paris, France

Received 20 July 2004; accepted 26 May 2005.

Background & Aims: The resistance of prolamines to digestive enzymes is thought to be a key contributor to the pathogenesis of celiac disease by promoting the intestinal entrance of peptides able to trigger inflammation in at-risk individuals. Oral administration of a bacterial prolyl-endopeptidase (PEP) therefore was proposed as a treatment for celiac disease. To delineate the feasibility of this treatment, the effect of PEP on gliadin peptides was assessed in vitro, and ex vivo during their transport across intestinal biopsy specimens of active celiac disease patients. Methods: In vitro degradation by PEP of 3H-labeled gliadin peptides 56–88 (33-mer) and 31–49, was analyzed by radio–reverse-phase high-performance liquid chromatography and mass spectrometry. For ex vivo studies, PEP and 3H-peptides were added together onto the mucosal side of duodenal biopsy specimens mounted in Ussing chambers, and peptide transport and digestion were assessed by radio–reverse-phase high-performance liquid chromatography. Results: Gliadin peptides were degraded partly by 20 mU/mL PEP both in vitro and ex vivo. This concentration of PEP decreased the amount of intact peptides 31–49 and 56–88 crossing the intestinal biopsy specimens of celiac disease patients, but could not prevent the intestinal passage of toxic or immunostimulatory metabolites. PEP concentrations of at least 500 mU/mL for 3 hours were required to achieve full detoxification of peptides and to prevent intestinal transport of active fragments. Conclusions: After prolonged exposure to high concentrations of PEP, the amount of immunostimulatory gliadin peptides reaching the local immune system in celiac patients is decreased. These results provide a basis to establish whether such conditions are achievable in vivo.

Abbreviations used in this paper:  CD, celiac disease , HPLC, high-performance liquid chromatography , MW, molecular weight , PEP, prolyl-endopeptidase , radio-RP-HPLC, radio–reverse-phase high-performance liquid chromatography , Rt, retention time

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported in part by Institut de Recherche des Maladies de l’Appareil Digestif, INSERM and Fondation Grâce de Monaco.

PII: S0016-5085(05)01118-2

doi:10.1053/j.gastro.2005.06.016

Refers to article:

  • A Search for the Holy Grail: Non-Toxic Gluten for Celiac Patients

    Marco Londei, Luigi Maiuri, Sonia Quaratino
    Gastroenterology September 2005 (Vol. 129, Issue 3, Pages 1111-1113)

Gastroenterology
Volume 129, Issue 3 , Pages 786-796, September 2005